Premenstrual Exacerbation of Symptoms in Multiple Sclerosis is Attenuated by Treatment with Weak Electromagnetic Fields

References

• Albert M. L. Treatment of pain multiple sclerosis. New England Journal of Medicine 1969; 280: 395
   Google Scholar
• Aldegunde M., Miguez I., Veira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• Algeri S., Bonati M., Curicio M. Biochemical effects of steroid contraceptive drugs on some neurotransmitters in the central nervous system. Pharmacology of steroid contraceptive drugs, S. Garattini, H. W. Berendes. Raven Press, New York 1977
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd edition. Washington, DC 1987
   Google Scholar
• Angeli A., Gatti G., Sartori M. L., DelPonte D., Garagnola R. Effect of exogenous melatonin on-human natural killer (NK) cell activity: an approach to the immunomodulatory role of the pineal gland. The pineal gland and cancer, D. Gupta, A. Attanasio, R. J. Reiter. Brain Research Promotion, London 1988
   Google Scholar
• Anton-Tay F., Chou C., Anton S., Wurtman R. J. Brain serotonin concentration elevation following intraperitoneal administration of melatonin. Science 1968; 162: 277–278
   PubMed Web of Science ®Google Scholar
• Arendt J. Melatonin assays in body fluids. Journal of Neural Transmission 1978; 13: 265–278, (suppl)
   Google Scholar
• Birk K., Rudick R. Pregnancy and multiple sclerosis. Archives of Neurology 1986; 43: 738–742
   Google Scholar
• Birk K., Ford C., Smeltzer S., Ryan D., Miller R., Rudick R. A. The clinical course of multiple sclerosis during pregnancy and the puerperium. Archives of Neurology 1990; 47: 738–742
   PubMed Web of Science ®Google Scholar
• Birner I. M. Pregnancy and multiple sclerosis. Case report. New York State Journal of Medicine 1945; 45: 634–635
   Google Scholar
• Brun J., Claustrat B., David M. Urinary melatonin, LH, oestradiol, progesterone excretion during the menstrual cycle or in women taking oral contraceptive. Acta Endocrinologica (Copenh.) 1987; 116: 145–149
   PubMedGoogle Scholar
• Cardarelli N. F. The role of a thymus-pineal axis in an immune mechanism of aging. Journal of Theoretical Biology 1990; 45: 397–405
   Google Scholar
• Carman J. S., Post R. M., Buswell R., Goodwin F. K. Negative effects of melatonin on depression. American Journal of Psychiatry 1976; 133: 1181–1186
   PubMed Web of Science ®Google Scholar
• Clare A. W. Hormones, behavior and the menstrual cycle. Journal of Psychosomatic Research 1985; 29: 225–232
   PubMed Web of Science ®Google Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamareni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Clifford D. B., Trotter J. L. Pain in multiple sclerosis. Archives Of Neurology 1984; 41: 1270–1272
   PubMedGoogle Scholar
• Cohen M. R., Pickar D., Dubois M., Nurenberger J., Roth Y., Cohen R. M., Gershon E., Bunney W. E. Clinical and experimental studies of stress and the opioid system. Annals of the New York Academy of Sciences 1982; 398: 711–719
   Google Scholar
• Coppen A., Kessel N. Menstruation and personality. British Journal of Psychiatry 1963; 109: 711–719
   PubMed Web of Science ®Google Scholar
• Dalton K. The premenstrual syndrome. Charles C. Thomas, Springfield, IL 1964
   Google Scholar
• Davidson D., Pullar I. A., Mawdsley C., Kinloch N., Yates M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Davis R. K., Maslow A. S. Multiple sclerosis in pregnancy: a review. Obstetrics and Gynecological Survey 1992; 47: 290–296
   PubMedGoogle Scholar
• Detels R., Clark V. A., Valdiviezo N. L., Visscher B. R., Malmgren R. M., Dudley J. P. Factors associated with a rapid course of multiple sclerosis. Archives of Neurology 1982; 39: 337–341
   PubMed Web of Science ®Google Scholar
• Duquette P., Girard M. Hormonal factors in susceptibility to multiple sclerosis. Current Opinion in Neurology and Neurosurgery 1993; 6: 195–201
   PubMedGoogle Scholar
• Duquette P., Pleines J., Charest L., Senecal-Quevillon M., Masse C. The increased susceptibility of women to multiple sclerosis. Canadian Journal of Neurological Sciences 1992; 19: 466–471
   PubMed Web of Science ®Google Scholar
• Ferin M. Endogenous opioid peptides and the menstrual cycle. Trends in Neurosciences 1984; 8: 194–196
   Google Scholar
• Fischman H. R. Multiple sclerosis: a two stage process. American Journal of Epidemiology 1981; 114: 244–252
   PubMed Web of Science ®Google Scholar
• Francis G. S., Antel J. P., Duquette P. Inflammatory demyelinating diseases of the CNS. Neurology in clinical practice, W. G. Bradley, B. Daroff, G. M. Fenichel, C. D. Marsden. Butterworth, Boston 1990; 1154
   Google Scholar
• Fraschini F., Reiter R. J. Role of melatonin and pineal peptides in neuroimmunomodulation. Plenum, New York 1990; 329
   Google Scholar
• Free M. J., Kaune W. T., Phillips R. D., Chen H. C. Endocrinological effects of strong 60-Hz electric fields on rats. Bioelectromagnetics 1981; 2: 105–122
   PubMedGoogle Scholar
• Garvey M. J., Wesner R., Godes M. Comparison of seasonal and nonseasonal affective disorder. American Journal of Psychiatry 1988; 145: 100–102
   PubMed Web of Science ®Google Scholar
• Ghezzi A., Caputo D. Pregnancy: a factor influencing the course of multiple sclerosis. European Neurology 1981; 20: 115–117
   PubMed Web of Science ®Google Scholar
• Grant I., Brown G., Harris T. Severely threatening events and marked life difficulties preceding onset and exacerbation of MS. Journal of Neurology Neurosurgery and Psychiatry 1989; 52: 8–13
   PubMed Web of Science ®Google Scholar
• Guerrero J. M., Reiter R. J. A brief survey of pineal gland-immune system interrelationships. Endocrine Research 1992; 18: 91–113
   PubMed Web of Science ®Google Scholar
• Gulshan S., McCruden A. B., Stimson W. H. Estrogen receptors in macrophages. Scandinavian Journal of Immunology 1990; 31: 691–697
   PubMed Web of Science ®Google Scholar
• Gusev E. I., Demina T. L., Boiko A. N., Pinegin B. V. Prolonged dynamic clinico-immunological observation of 85 patients with definite multiple sclerosis: first steps towards monitoring process activity. Journal of Neurology 1994; 24: 500–510
   Google Scholar
• Hackman R. M., Graves H. B. Corticosterone levels in mice exposed to high intensity electric fields. Behavioral Neural Biology 1981; 32: 201–213
   PubMedGoogle Scholar
• Halbreich U., Endicott J. Relationship of dysphoric premenstrual changes to depressive disorders. Acta Psychiatrica scandinauica 1985; 71: 331–338
   PubMed Web of Science ®Google Scholar
• Halbreich U., Holtz I., Paul L. Premenstrual changes. Impaired hormonal homeostasis. Neurologic Clinics 1986; 6: 173–194
   Google Scholar
• Hallman J. The premenstrual syndrome: an equivalent of depression. Acta Psychiatrica Scandinavica 1986; 73: 403–411
   PubMed Web of Science ®Google Scholar
• Hariharasubramanian N., Nair N. P. V., Pilapil C. Circadian rhythm of plasma melatonin and cortisol during the menstrual cycle. The pineal gland endocrine aspects, G. M. Brown, S. D. Wainwright. Pergamon Press, Oxford 1985; 31–36
   Google Scholar
• Hyyppa M. T., Joima T., Riekkinen P., Rinne U. K. Effects of L-tryptophan on central indoleamire metabolism and short-lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission 1975; 37: 297–304
   PubMed Web of Science ®Google Scholar
• Israel S. I. Premenstrual tension. Journal of the American Medical Association 1938; 110: 1721–1726
   Google Scholar
• Jakovleva M. I. The physiological mechanisms of electromagnetic fields. Medicine, Leningrad 1975
   Google Scholar
• Jankovic B. D., Isakovic K., Petrovic S. Effect of pinealectomy on immune reactions in the rat. Immunology 1970; 18: 1–5
   PubMed Web of Science ®Google Scholar
• Junquiera L. C., Carneiro J. Basic histology, 4th ed. Lange Medical Publications, Los Altos, CA 1983
   Google Scholar
• Kavaliers M., Ossenkopp K. P. Tolerance to morphine-induced analgesia in mice: magnetic fields function as environmental specific cues and reduce tolerance development. Life Sciences 1985; 37: 1125–1135
   PubMed Web of Science ®Google Scholar
• Kavaliers M., Ossenkopp K. P. Stress-induced opioid analgesia and activity in mice: inhibitory influences of exposure to magnetic fields. Psychopharmacology 1986a; 89: 440–443
   PubMed Web of Science ®Google Scholar
• Kavaliers M., Ossenkopp K. P. Magnetic fields differentially inhibit mu, delta, kappa and sigma opiate-induced analgesia in mice. Peptides 1986b; 7: 449–453
   PubMed Web of Science ®Google Scholar
• Kavaliers M., Ossenkopp K. P. Magnetic field inhibition of morphine-induced analgesia and behavioral activity in mice: evidence for involvement of calcium ions. Brain Research 1986c; 379: 30–38
   PubMed Web of Science ®Google Scholar
• Kavaliers M., Ossenkopp K. P. Magnetic fields, opioid systems, and day-night rhythms of behavior. Electromagnetic fields and circadian rhythm-micity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 95–117
   Google Scholar
• Kavaliers M., Ossenkopp K. P., Hirst M. Magnetic fields abolish the enhanced nocturnal analgesic response to morphine in mice. Physiology & Behavior 1984; 32: 261–264
   PubMed Web of Science ®Google Scholar
• Kholodov I. A. The influence of electromagnetic and magnetic fields on the nervous system. Joint research service, Washington 1966, IPRS-37102, TT-66-33531
   Google Scholar
• Kisser W., Harrer G. Amino acid determinations in serum of patients with multiple sclerosis. Wiener Klinische Wochenschrift 1974; 86: 80–82
   PubMed Web of Science ®Google Scholar
• Korn-Lubetzki I., Kahana E., Cooper G., Abramsky O. Activity of multiple sclerosis during pregnancy and puerperium. Annals ff Neurology 1984; 16: 229–231
   PubMed Web of Science ®Google Scholar
• Law S. The regulation of the menstrual cycle and its relationship co the moon. Acta Obstetrica Gynaecologica Scandinavica 1986; 65: 45–49
   PubMed Web of Science ®Google Scholar
• Lennon V. A., Carnegie P. R. Immunopharmacological disease: a break in tolerance to receptor sites. Lancet 1971; 2: 630–633
   Google Scholar
• Lewy A. J., Wehr T. A., Goodwin F. K. Light suppresses melatonin secretion in humans. Science 1980; 210: 1267–1269
   PubMed Web of Science ®Google Scholar
• Lissoni P., Esposti D., Esposti G., Mauri R., Resentini M., Morabito F., Fumagali P., Santagostino A., Delitala G., Fraschini A. A clinical study on the relationship between the pineal gland and the opioid system. Journal of Neural Transmission 1986; 65: 63–73
   PubMed Web of Science ®Google Scholar
• Luca N., Hategdn D. Determination of serotonin content and ceruloplasmin activity of blood and CSF amino acid level in multiple sclerosis. Reveu Roumania Medicu Neurologica Psychiatrica 1986; 24: 153–159
   Google Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. The pineal gland and the circadian, opiatergic, immunoregulatory role of melatonin. Annals of the New York Academy of Science 1987a; 496: 67–77
   PubMed Web of Science ®Google Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. Melatonin counteracts the effect of acute stress on the immune system via an opiatergic system. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1987b; 277–279
   Google Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. Role of the pineal gland in immunity. III: Melatonin antagonizes the immunosuppressive effect of acute stress via an opiatergic mechanism. Immunology 1988; 63: 465–469
   PubMed Web of Science ®Google Scholar
• Magos A., Studd J. Effects of the menstrual cycle on medical disorders. British Journal of Hospital Medicine 1985; 33: 68–77
   PubMedGoogle Scholar
• Markianos M., Sfagos C. Altered serotonin uptake kinetics in multiple sclerosis. Journal of Neurology 1988; 235: 236–237
   PubMed Web of Science ®Google Scholar
• Martin J. B., Reichlin S. Clinical neuroendocrinology. F. A. Davis, Philadelphia 1987; 639–655
   Google Scholar
• McCall M., Sutherland J., Acheson E. The frequency of multiple sclerosis in Western Australia. Acta Neurologica Scandinavica 1969; 45: 151–165
   PubMed Web of Science ®Google Scholar
• Michaelson S. M., Lu S. T. Factors in postmeridial hormone changes among rats in electric field exposure studies. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 77–94
   Google Scholar
• Millar J. H. D., Allison R. S., Cheeseman E. A., Merrett I. D. Pregnancy as a factor influencing relapse in disseminated sclerosis. Brain 1959; 82: 417–426
   PubMed Web of Science ®Google Scholar
• Moszkowska A., Kordon C., Ebels I. Biochemical fractions and mechanisms involved in the pineal modulation of pituitary gonadotropin release. The pineal gland, G. E.W. Wolstenholme, J. Knight. Churchill-Livingstone, London 1971; 241–258
   Google Scholar
• Parry B. L., Rosenthal N., Tamarkin L., Wehr T. Treatment of a patient with season premenstrual syndrome. American Journal of Psychiatry 1987; 144: 762–766
   PubMed Web of Science ®Google Scholar
• Parry B. L., Berga S. L., Mostofi N., Sependa P. A., Kripke D. F., Gillin I. C. Morning versus evening bright light treatment of late luteal phase dysphoric disorder. American Journal of Psychiatry 1989; 146: 1215–1217
   PubMed Web of Science ®Google Scholar
• Parry B. L., Berga S. L., Kripke D. F., Klauber M. R., Laughlin G. A., Yen S. S. C., Gillin J. C. Altered wave form of plasma noturnal melatonin secretion in premenstrual depression. Archives of General Psychiatry 1990; 47: 1139–1146
   PubMed Web of Science ®Google Scholar
• Penny R. Melatonin excretion in normal males and females: increase during pregnancy. Metabolism 1982; 31: 816–822
   PubMed Web of Science ®Google Scholar
• Pierpaoli W., Maestroni G. J. M. Melatonin: a principal neuroimmunoregulatory and anti-stress hormone: its anti-aging effects. Immunology Letters 1987; 16: 355–362
   PubMed Web of Science ®Google Scholar
• Pierpaoli W., Maestroni G. J. M. Neuroimmunomodulation: some recent views and findings. International Journal of Neuroscience 1988; 39: 25–33
   Web of Science ®Google Scholar
• Pies R. W. Fluoxetine treatment of premenstrual syndrome. Journal of Clinical Psychiatry 1990; 51: 348
   PubMedGoogle Scholar
• Poser S., Poser W. Multiple sclerosis and gestation. Neurology 1983; 33: 1422–1427
   PubMed Web of Science ®Google Scholar
• Pranzatelli M., Snodgrass S. The pharmacology of myoclonus. Clinical Neuropharmcology 1985; 8: 99–130
   PubMed Web of Science ®Google Scholar
• Quinn N. P., Marsden C. D. Menstrual-related fluctuations in Parkinson's disease. Movement Disorders 1986; 1: 85–87
   PubMedGoogle Scholar
• Reid R. L. Endogenous opioid activity and the premenstrual syndrome. Lancet 1983; 1: 786
   PubMedGoogle Scholar
• Reid R. L., Yen S. S. C. Premenstrual syndrome. American Journal of Obstetrics and Gynecology 1981; 139: 85–104
   PubMed Web of Science ®Google Scholar
• Reid R. L., Yen S. S. C. The premenstrual syndrome. Clinical Obstetrics and Gynecology 1983; 26: 709–716
   Google Scholar
• Reiter R. J. Pineal gland. Interface between the photoperiodic environment and the endocrine system. Trends in Endocrinology and Metabolism 1991; 2: 13–19
   PubMed Web of Science ®Google Scholar
• Rella W., Lapin V. Immunocompetence of pinealectomized and simulateneously pinealectomized and thymectornized rats. Oncology 1976; 33: 3–6
   PubMed Web of Science ®Google Scholar
• Rickels K., Freeman E. W., Sondheimer S., Albert J. Fluoxetine in the treatment of premenstrual syndrome. Current Therapeutic Research 1990; 48: 161–166
   Web of Science ®Google Scholar
• Rosenberg G. A., Appenzeller O. Amantadine, fatigue, and multiple sclerosis. Archives of Neurology 1988; 45: 1104–1106
   PubMed Web of Science ®Google Scholar
• Rosenthal N. E., Sack D. A., Carpenter C. J., Parry B., Mendelson W. B., Wehr T. A. Antidepressant effects of light in seasonal affective disorder. American Journal of Psychiatry 1985; 142: 163–170
   PubMed Web of Science ®Google Scholar
• Roszman T. L., Jackson J. C., Cross R. J., Titus M. J., Markesbery W. R., Brooks W. H. Neuroanatomic and neurotransmitter influences on immune function. The Journal of Immunology 1985; 135: 769S–772S
   PubMed Web of Science ®Google Scholar
• Rubinow D. R., Hoban M. C., Grover G. N. Menstrually-related mood disorders. Hypothalamic dysfunction in neuropsychiatric disorders, D. Nerozzi, F. K. Goodwin, E. Costa. Raven Press, New York 1987; 335–346
   Google Scholar
• Rudolph K., Wirz-Justice A., Krauchi K., Feer H. Static magnetic fields decrease nocturnal pineal cAMP in the rat. Brain Research 1988; 446: 159–160
   PubMed Web of Science ®Google Scholar
• Russell J. W., Windebank A. J., Harper C. M. Treatment of stable chronic demyelinating polyneuropathy with 3, 4-diaminopyridine. Mayo Clinic Proceedings 1995; 70: 532–539
   PubMed Web of Science ®Google Scholar
• Sandyk R. The Pineal gland and the menstrual cycle. International Journal of Neuroscience 1992a; 63: 197–204
   PubMed Web of Science ®Google Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience 1992b; 66: 237–250
   PubMed Web of Science ®Google Scholar
• Sandyk R. The pineal gland and multiple sclerosis, (Editorial). International Journal of Neuroscience 1992c; 63: 206–215
   Web of Science ®Google Scholar
• Sandyk R. Multiple sclerosis: the role of puberty and the pineal gland in its pathogenesis. International Journal of Neuroscience 1993; 68: 209–225
   PubMedGoogle Scholar
• Sandyk R. Further observations on the effects of external picotesla range magnetic fields on visual memory and visuospatial functions in multiple sclerosis. International Journal of Neuroscience 1994a; 77: 203–227
   PubMed Web of Science ®Google Scholar
• Sandyk R. Rapid normalization of visual evoked potentials by picotesla range magnetic fields in chronic progressive multiple sclerosis. International Journal of Neuroscience 1994b; 77: 243–259
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. The pineal gland in multiple sclerosis. International Journal of Neuroscience 1991; 61: 61–67
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal plasma melatonin and alpha-melanocyte stimulating hormone levels during exacerbation of multiple sclerosis. International Journal of Neuroscience 1992; 67: 173–186
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders. International Journal of Neuroscience 1993a; 68: 227–240
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal melatonin secretion in suicidal patients with multiple sclerosis. International Journal of Neuroscience 1993b; 71: 173–182
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Relationship of nocturnal melatonin levels to duration and course of multiple sclerosis. International Journal of Neuroscience 1994a; 75: 229–231
   PubMedGoogle Scholar
• Sandyk R., Awerbuch G. I. The co-occurrence of multiple sclerosis and migraine headaches: the serotonergic link. International Journal of Neuroscience 1994b; 76: 249–257
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal of Neuroscience 1993a; 70: 97–105
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. Magnetic fields normalize visual evoked potentials and brainstem auditory evoked potentials in multiple sclerosis. International Journal of Neuroscience 1993b; 68: 241–253
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Resolution of longstanding symptoms of multiple sclerosis by application of picotesla range magnetic fields. International Journal of Neuroscience 1993; 70: 255–269
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. Multiple sclerosis: Improvement of visuoperceptive functions by picotesla range magnetic fields. International Journal of Neuroscience 1994a; 74: 177–189
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Improvement by picotesia range magnetic fields of perceptual-motor performance and visual memory in a patient with chronic progressive multiple sclerosis. International Journal of Neuroscience 1994b; 78: 53–66
   PubMed Web of Science ®Google Scholar
• Sandyk R., Bamford C. R., Iacono R. P. Menstrual-related fluctuations in Tourette's syndrome. International Journal of Neuroscience 1987; 35: 237–239
   PubMed Web of Science ®Google Scholar
• Schapira K., Poskanzer D. C., Newell D. J., Miller H. Marriage, pregnancy and multiple sclerosis. Brain 1966; 89: 419–428
   PubMed Web of Science ®Google Scholar
• Schipper H. M. Neurology of sex steroids and oral contraceptives. Neurologic Clinics 1986; 4: 721–751
   PubMed Web of Science ®Google Scholar
• Schuckit M. A., Daly V., Herman G., Hineman S. Premenstrual symptoms and depression in a university population. Diseases of the Nervous System 1975; 36: 516–517
   PubMedGoogle Scholar
• Schuurs A. H., Verheul H. A. Effects of gender and sex steroids on the immune response. Journal of Steroid Biochemistry 1990; 35: 157–172
   PubMedGoogle Scholar
• Semm P. Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology 1983; 76A: 683–689
   Web of Science ®Google Scholar
• Semm P., Schneider T., Vollrath L. Effects of an earth-strength magnetic field on electrical activity of pineal cells. Nature 1980; 288: 607–608
   PubMed Web of Science ®Google Scholar
• Semm P., Demaine C., Vollrath L. The effects of sex hormones, prolactin, and chorionic gonadotropin on pineal electrical activity in guinea pigs. Cellular and Molecular Neurobiology 1981; 1: 259–269
   PubMed Web of Science ®Google Scholar
• Shibasaki H., Kuroiwa Y. Painful tonic seizures in multiple sclerosis. Archives of Neurology 1974; 30: 47–51
   PubMedGoogle Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Stone A. B., Pearlstein T. B., Brown W. A. Fluoxetine in the treatment of late luteal phase dysphoric disorder. Journal of Clinical Psychiatry 1991; 52: 290–293
   PubMed Web of Science ®Google Scholar
• Stoupel E., Keret R., Assa S., Kaufman H., Shimshoni M., Laron Z. Secretion of growth hormone, prolactin and corticosteroids during different levels of geomagnetic activity. Neuroendocrinology Letters 1983; 5: 365–368
   Web of Science ®Google Scholar
• Stumpf W. E., Sar M. Steroid hormone target cells in the periventricular brain: relationship to peptide hormone producing cells. Federation Proceedings 1977; 36: 1973–1977
   PubMedGoogle Scholar
• Sweeney W. J. Pregnancy and multiple sclerosis. American Journal of Obstetrics and Gynecology 1955; 66: 124–130
   Google Scholar
• Tabaddor K., Wolfson L. I., Sharpless N. S. Ventricular fluid homovanillic acid and 5-hydroxyin-doleacetic acid concentrations in patients with movement disorders. Neurology 1978; 28: 1249–1253
   PubMed Web of Science ®Google Scholar
• Terenius L. Clinical aspects. Endorphins, J. B. Malick, R. M.S. Bell. Marcel Dekker, New York 1982; 229–255
   Google Scholar
• Tillman A. J. B. The effect of pregnancy on multiple sclerosis and its management. Research Publications of the Association for Research in Nervous and Mental Disease 1950; 28: 548–582
   PubMedGoogle Scholar
• Van Diemen H. A. M., Polman C. H., Van Dongen M. M. M. M., Nauta J. J. P., Strijers R. L. M., Van Loenen A. C., Bertelsmann F. W., Koetsier J. C. 4-aminopyridine induces functional improvement in multiple sclerosis patients: a neuropsychiological study. Journal of the Neurological Sciences 1993; 116: 220–226
   PubMed Web of Science ®Google Scholar
• Wainerdi H. R. Does the multiple-sclerosis syndrome begin at puberty. Boston Medical Quarterly 1961; 12: 44–47
   PubMedGoogle Scholar
• Walker J. M., Khachaturian H., Watson S. J. Some anatomical and physiological interactions among noradrenergic systems and opioid peptides. Frontiers in Clinical Neurosciences 1984; 2: 74–82
   Google Scholar
• Walton I. N. Brain's diseases of the nervous system. Oxford University Press, Oxford 1977; 548
   Google Scholar
• Warren S., Greenhill S., Warren K. Emotional stress and the development of MS: case-control evidence of a relationship. Journal of Chronic Disease 1982; 35: 821–831
   PubMedGoogle Scholar
• Weber R. J., Pert C. B. Opiatergic modulation of the immune system. Central and peripheral endorphins: basic and clinical aspects, E. E. Miller, A. R. Genazzani. Raven Press, New York 1984; 35–42
   Google Scholar
• Webley G. E., Leidenberger F. The circadian pattern of melatonin and its positive relationship with progesterone in women. Journal of Clinical Endocrinology 1986; 63: 323–328
   PubMed Web of Science ®Google Scholar
• Wehr T. A., Rosenthal N. E. Seasonality and affective illness. American Journal of Psychiatry 1989; 146: 829–839
   PubMed Web of Science ®Google Scholar
• Wehrenberg W. B., Wardlaw S. L., Frantz A. G., Ferin M. Beta-endorphin in hypophyseal portal blood variations throughout the menstrual cycle. Endocrinology 1982; 111: 879–881
   PubMed Web of Science ®Google Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C., Wiltschko W., Vollrath L. Effects of an artifical magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• Wetterberg L., Arendt J., Paunier L., Sizonenko P. C., Von Donselaer W., Heyden T. Human serum melatonin changes during the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 1976; 42: 185–188
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Stevens R. G., Anderson L. E. Effects of electromagnetic field exposure on neuroendocrine function. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 29–50
   Google Scholar
• Williams J. T., Egan T. M., North R. A. Enkephalin opens potassium channels on mammalian central neurones. Nature 1982; 299: 74–77
   PubMed Web of Science ®Google Scholar
• Yen S. S. C. The human menstrual cycle. Reproductive endocrinology, physiology, pathophysiology and clinical management, S. S.C. Yen, R. B. Jaffe. W.B. Saunders, Philadelphia 1986; 200–236
   Google Scholar